Trials / Recruiting
RecruitingNCT07305922
Delayed Cerebral Infarction Beyond Endoluminal Spasmolysis and Induced Hypertension
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 200 (estimated)
- Sponsor
- Region Stockholm · Other Government
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
An observational study of patients with emerging or established severe cerebral vasospasm after subarachnoid haemorrhage, employing multimodal neuromonitoring.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Induced hypertension with norepinephrine | Induced hypertension with norepinephrine and/or dobutamine to attain clinically established goals of cerebral perfusion pressure in a stepwise fashion, according to clinical routine. |
| DRUG | Endoluminal Spasmolysis | Endoluminal spasmolysis of cerebral arteries using i.a. Nimodipine, according to clinical protocol and neurointerventionist discretion. |
Timeline
- Start date
- 2025-12-01
- Primary completion
- 2029-12-31
- Completion
- 2030-12-31
- First posted
- 2025-12-26
- Last updated
- 2025-12-26
Locations
1 site across 1 country: Sweden
Source: ClinicalTrials.gov record NCT07305922. Inclusion in this directory is not an endorsement.